SCHEMBL8064334

SCHEMBL8064334

O=C1C(CCCc2cc(F)cc(F)c2)c2cc(-c3ccc(F)c(Cl)c3)ccc2N1c1ccccn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ MALT1 Q9UDY8 1/20 0.35
▸ SUCNR1 Q9BXA5 3/20 0.33
▸ CD274 Q9NZQ7 2/20 0.33
▸ HTR7 P34969 1/20 0.33
▸ GRM2 Q14416 2/20 0.32
▸ HTR2A P28223 1/20 0.32
▸ GRIN1 Q05586 3/20 0.32
▸ GRIN2B Q13224 3/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ POLB P06746 2/20 0.31
▸ PDCD1 Q15116 1/20 0.31
▸ ALOX5 P09917 1/20 0.31
▸ GRM4 Q14833 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30
▸ HIF1A Q16665 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12678469 0.89 SMN1; SMN2 (0.41) TSHRNPSR1SMN1; SMN2MALT1SUCNR1
SCHEMBL12678475 0.80 SMN1; SMN2 (0.41) SMN1; SMN2CD274GRM2GRIN1GRIN2B
SCHEMBL12678468 0.79 ALOX5 (0.38) TSHRNPSR1MALT1SUCNR1GRM2
SCHEMBL3031553 0.71 ITGB2 (0.41) TSHRNPSR1MALT1SUCNR1CD274
SCHEMBL8063130 0.71 ITGB2 (0.41) TSHRNPSR1MALT1SUCNR1CD274
SCHEMBL12678446 0.70 DRD2 (0.42) SMN1; SMN2HTR7GRIN1GRIN2BPOLB
SCHEMBL12678479 0.70 GRIN1 (0.36) GRM2GRIN1GRIN2BALDH1A1ALOX5
SCHEMBL8815542 0.69 SLC6A7 (0.36) GRM2GRIN1GRIN2BALDH1A1ALOX5
SCHEMBL12678473 0.67 BACE1 (0.35) SMN1; SMN2GRM2GRIN1GRIN2BALOX5
SCHEMBL2785731 0.67 GRM2 (0.40) TSHRNPSR1MALT1GRM2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009045386-A1 N-SUBSTITUTED OXINDOLINE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS MERCK & CO., INC. (US) 2009-04-09 — — WO disclosed
Send feedback